S.Korea’s extra budget approved; IBs lift economic forecast
South Korea’s National Assembly, controlled by the ruling Democratic Party, on Friday passed the country’s new extra budget worth 31.8 t...
Allianz-backed Koh Young’s brain surgery robot set for US debut by end-August
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, is set to install its brain ...
KakaoBank rallies after winning Thai virtual banking license
Shares in KakaoBank Corp. soared as much as 17% to hit their highest level in nearly three years on Friday after the South Korean internet-only bank...
Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
In a move that could reshape the global memory industry’s competitive dynamics, Nvidia Corp. has chosen US chipmaker Micron Technology Inc. as...
Woori Financial wins approval for Tongyang, ABL Life acquisition
Woori Financial Group Inc., South Korea’s fourth-largest financial services provider, has received conditional approval from the country&rsquo...
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Koh Young gets OK from FDA for brain surgery robot
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...
Korean lenders to Accell warn they may boycott KKR
KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...
JLK gets OK from FDA for ICH diagnosis solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Korean Air gets EU approval for Asiana merger
The European Commission (EC), the European Union (EU) antitrust body, approved the merger between Korean Air Lines Co. and Asiana Airlines Inc. on N...
Noul's miLab registered FDA's Class I
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...
Samsung Bioepis gets EC's approval for Opuviz
South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Samyang enters Australia, New Zealand with allulose approval
South Korean chemical and food ingredient manufacturer Samyang Corp. said on Wednesday that it has become the first allulose producer to secure appr...
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
SK Innovation-SK E&S merger gains shareholders’ nod
SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
South Korea to extend export missile range from 300 km to 500 km
South Korea has decided to extend the range of missiles for export to 500 kilometers from the current 300 km after accepting requests to do so from ...
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Lotte India, Havmor to merge to raise $722.4 mn in sales
South Korean confectionery giant Lotte Wellfood Co. will merge its Indian subsidiaries — Lotte India Co. and Havmor Ice Cream Pvt — to b...
